{"product_id":"bundle-titan","title":"TITAN Bundle","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003eThe \u003cstrong\u003eTITAN Bundle\u003c\/strong\u003e is a four-vial research stack spanning two research axes: \u003cstrong\u003eGrow-H 10 mg\u003c\/strong\u003e (CJC-1295 no DAC + Ipamorelin), \u003cstrong\u003eIpamorelin 10 mg\u003c\/strong\u003e, \u003cstrong\u003eBPC-157 10 mg\u003c\/strong\u003e and \u003cstrong\u003eTB-500 5 mg\u003c\/strong\u003e — at 10% off the individual vial prices.\u003c\/p\u003e\n\u003cp\u003eOn the growth-hormone axis, the long-acting form of \u003cstrong\u003eCJC-1295\u003c\/strong\u003e produced prolonged GH and IGF-I elevations in healthy adults\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1210\/jc.2005-1536\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e, while \u003cstrong\u003eIpamorelin\u003c\/strong\u003e is the first selective growth-hormone secretagogue described in the literature\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1530\/eje.0.1390552\" target=\"_blank\" rel=\"noopener\"\u003e[3]\u003c\/a\u003e\u003c\/sup\u003e. On the repair axis, \u003cstrong\u003eBPC-157\u003c\/strong\u003e was studied in tendon-healing models\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1152\/japplphysiol.00945.2010\" target=\"_blank\" rel=\"noopener\"\u003e[5]\u003c\/a\u003e\u003c\/sup\u003e and \u003cstrong\u003eTB-500\u003c\/strong\u003e is synthetic full-length thymosin beta-4, an actin-regulating peptide that promoted cell migration and repair signalling in preclinical studies\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1038\/nature03000\" target=\"_blank\" rel=\"noopener\"\u003e[8]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eEach vial is supplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution, and each compound has its own lot-specific third-party certificate of analysis, available on request. \u003cem\u003eFindings above come from preclinical and early-phase clinical research on these molecules and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides","offers":[{"title":"Default Title","offer_id":47510995730594,"sku":"BND-IRONCLAD","price":252.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/bundle-ironclad.png?v=1786402416","url":"https:\/\/primelabpeptides.com\/products\/bundle-titan","provider":"Prime Lab Peptides","version":"1.0","type":"link"}